Novo Nordisk A/S
NYSE: NVO
$65.91
+$1.54 (+2.4%)
Real Time Data Delayed 15 Min.
NVO Stock Chart and Intraday Price
NVO Stock Data
| Asset Type | Common Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | NOVO ALLE DK 2880, BAGSVAERD DENMARK, DK |
| Fiscal Year End | December |
| Latest Quarter | 2023-12-31 |
| Market Cap | 560,772.87M USD |
| Shares Outstanding | 4,461,910,000 |
NVO Articles
Live Updates Live Coverage Has Ended This Dial Goes to 5 4:18 pm The Vanguard S&P 500 ETF closed Friday at 546.26, up 0.6% for the day. The Voo closed higher every day this week, and ends up 5.3%...
Published:
Last Updated:
Live Updates Live Coverage Has Ended No News Is Good News 4:18 pm The trading day has ended, and the Federal Reserve meeting, too. As expected, the Fed once again decided to leave interest rates...
Published:
Last Updated:
Live Updates Live Coverage Has Ended S&P 500 Extends Its Winning Streak 4:18 pm The S&P 500 closed up 0.6% for Tuesday, extending its winning streak to six straight days. Trade Talks Keep...
Published:
Last Updated:
Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so. Trading at $852 per...
Published:
Live Updates Live Coverage Has Ended All's Well That Ends Green 4:30 pm All three major market indices ended in the green Friday. The Dow Jones Industrial Average closed up a bare 0.05%, while the...
Published:
Last Updated:
Live Updates Live Coverage Has Ended A Bad Day for Investors Got Much, Much Worse 4:08 pm A trading day that started out bad for investors this morning ended in a market rout. By the time the closing...
Published:
Last Updated:
Novo Nordisk sees the obesity drug market expanding to $100 billion by 2030. With promising new treatments in the pipeline, 24/7 Wall St. projects huge upside through the end of the decade.
Published:
One man’s trash may be another man’s treasure, but dumpster diving when investing carries risks. You have to wade through a lot of junk to potentially find a nugget of gold. While cheap stocks...
Published:
Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These stocks give you a steady stream of income and often appreciate during...
Published:
Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to...
Published:
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was over. It said the Danish pharmaceutical had sufficient supply of its...
Published:
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. About This Article Just this morning, the US FDA said Novo Nordisk’s popular...
Published:
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
Published:
The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough to gauge which innovative biotech firms will have something genuinely...
Published:
Eli Lilly (NYSE: LLY) doesn’t really need much of an introduction. It has become a household name due to its obesity and diabetes treatments. LLY stock has delivered exponential returns from 2018...
Published:
Last Updated:
